Start or Grow a Business

Start or Grow a Business

YOU HAVE QUESTIONS.
WE HAVE ANSWERS.

No matter your business needs, the Economic Development Partnership of North Carolina is ready to assist.

COVID relief banner

Start a business icon

START A BUSINESS

If you have big dreams, you’ve come to the right place. We’ll help you lay the foundation for future success.

Get Started

Grow a business icon

GROW AN EXISTING BUSINESS

Our team works with companies across the state to nurture and grow their organization. This personalized support helps hundreds of businesses statewide each year.

Grow Your Business

Export assistance icon

Get Export Assistance

Take your business global. We’re dedicated to helping companies large and small address their export needs, navigate trade agreements and language barriers, attend trade shows, file the right paperwork and more.

Go Global

NEWSLETTER

Stay up to date with us. Get email alerts on the latest news and upcoming events.

Subscribe

NEWS & EVENTS

EDPNC logo
04/22/2024
Rural Infrastructure Authority Approves 31 Grants to Rural Communities to Create 565 Jobs and more than $211M in Private Investment
The North Carolina Rural Infrastructure Authority (RIA) has approved 31 grant requests to local governments totaling $10,982,835. These grants are for projects that have committed to creating 565 jobs and will attract more than $211 million in private investment. The Rural Infrastructure Authority is a 17-member board that awards Rural, Community Development Block Grant (CDBG), and Utility…
Read More
EDPNC logo
04/11/2024
FUJIFILM Diosynth Invests $1.2B in Holly Springs, North Carolina, Manufacturing Facility, Creating 680 New Jobs
FUJIFILM Diosynth Biotechnologies North Carolina, Inc., a world-leading contract development and manufacturing organization (CDMO), will invest $1.2 billion to expand its biopharmaceutical manufacturing facility in Holly Springs, North Carolina, creating 680 new jobs in Wake County. Initial investments of the FUJIFILM’s Holly Springs operation included $2 billion in 2021, making it the largest end-to-end biopharmaceutical…
Read More

More News

0